MASLD and sarcopenia research (2012-2025): a multi-database bibliometric analysis.

Keyan Gao1, Liwen Xun1, Shalei Hao1

  • 1Department of Endocrinology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Summary

Research on metabolic dysfunction-associated steatotic liver disease (MASLD) and sarcopenia shows a growing focus on early fibrosis risk and lifestyle interventions. Understanding the liver-muscle axis is key for personalized nutrition strategies.